Medical Diagnostic Test Kit Issues Falsely Elevated Estradiol Results
Siemens Healthcare is recalling ADVIA Centaur Enhanced Estradiol diagnostic kits because plasma specimens may show falsely elevated results, potentially leading clinicians to misinterpret patient test results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a diagnostic device. The source text does not report any illnesses, injuries, or hospitalizations. The hazard is a potential for clinical misinterpretation through false diagnostic results, which constitutes a risk-of-harm scenario without reported actual injury.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling the ADVIA Centaur Enhanced Estradiol (eE2) 100T, an in vitro diagnostic test used to measure estradiol levels in patient samples. The product has been distributed worldwide, with 2,315 units affected.
The test can produce falsely elevated results when analyzing plasma specimens. These incorrect results could lead clinicians to misinterpret patient test outcomes and make inappropriate clinical decisions based on inaccurate diagnostic data.
The recall affects all lot numbers of the product. Affected lots are identified by the UDI codes provided by the manufacturer.
Healthcare providers using this test should contact Siemens Healthcare Diagnostics for instructions on how to proceed. Patients who may have been tested with affected kits should consult with their healthcare provider about the potential impact on their test results.
The recalled product
- Product
- ADVIA Centaur Enhanced Estradiol (eE2) 100T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10490889 All lots
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Affected units
- 2,315
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · falsely elevated results
See all →- HighEstrone RIA kits give falsely increased results from a bovine albumin lot
FDA (Devices) · 2025-07-30
- HighAbbott Alinity c Hemoglobin Reagent Kit may produce falsely elevated test results
FDA (Devices) · 2022-08-03
- HighEstradiol diagnostic test kits recalled for falsely elevated results
FDA (Devices) · 2022-05-11